Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-071311
Date:2021-12-27
Issuer: SORRENTO THERAPEUTICS, INC. (SRNE)
Original Submission Date:

Reporting Person:

JANDA KIM
C/O SORRENTO THERAPEUTICS, INC.
4955 DIRECTORS PLACE SAN DIEGO, CA 92121

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-12-27 M 3,000 a $4.00 6,000 direct
COMMON STOCK 2021-12-27 S 3,000 d $5.88 3,000 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
NON-QUALIFIED STOCK OPTION 4.0 2021-12-27 deemed execution date M 3,000 (d) 2013-01-01 2022-02-06 common stock 3,000 $4.00 0 direct
Footnotes
IDfootnote
f1 this transaction was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person.

Elevate your investments